RAPT Therapeutics, Inc. (RAPT)
NASDAQ: RAPT · IEX Real-Time Price · USD
2.790
-0.090 (-3.12%)
At close: Jul 2, 2024, 4:00 PM
2.860
+0.070 (2.51%)
After-hours: Jul 2, 2024, 4:39 PM EDT
RAPT's stock price has decreased by -85.29% in the past year and price targets may not have had time to catch up.
RAPT Therapeutics Analyst Ratings
Total Analysts
11
Consensus Rating
Hold
Price Target
$18.00
Upside
+545.16%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wolfe Research | Wolfe Research | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | May 14, 2024 |
| Barclays | Barclays | Buy → Hold Downgrades $13 → $4 | Buy → Hold | Downgrades | $13 → $4 | +43.37% | May 10, 2024 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | May 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Apr 10, 2024 |
| JP Morgan | JP Morgan | Hold Maintains $15 → $13 | Hold | Maintains | $15 → $13 | +365.95% | Mar 27, 2024 |
| UBS | UBS | Strong Buy → Hold Downgrades $61 → $10 | Strong Buy → Hold | Downgrades | $61 → $10 | +258.42% | Feb 22, 2024 |
| Barclays | Barclays | Buy Maintains $35 → $13 | Buy | Maintains | $35 → $13 | +365.95% | Feb 21, 2024 |
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades $10 | Buy → Hold | Downgrades | $10 | +258.42% | Feb 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Feb 21, 2024 |
| JP Morgan | JP Morgan | Buy → Hold Downgrades $35 → $15 | Buy → Hold | Downgrades | $35 → $15 | +437.63% | Feb 21, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Feb 20, 2024 |
| Evercore ISI Group | Evercore ISI Group | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Feb 16, 2024 |
| Wolfe Research | Wolfe Research | Buy Initiates $39 | Buy | Initiates | $39 | +1,297.85% | Feb 15, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $32 → $35 | Buy | Maintains | $32 → $35 | +1,154.48% | Nov 30, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $41 | Strong Buy | Reiterates | $41 | +1,369.53% | Nov 15, 2023 |
| Berenberg | Berenberg | Strong Buy Initiates $34 | Strong Buy | Initiates | $34 | +1,118.64% | Sep 14, 2023 |
| JP Morgan | JP Morgan | Buy Maintains $39 → $32 | Buy | Maintains | $39 → $32 | +1,046.95% | Aug 16, 2023 |
| Piper Sandler | Piper Sandler | Buy Maintains $28 → $31 | Buy | Maintains | $28 → $31 | +1,011.11% | Aug 14, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $41 | Strong Buy | Reiterates | $41 | +1,369.53% | Aug 14, 2023 |
| Stifel | Stifel | Strong Buy Initiates $40 | Strong Buy | Initiates | $40 | +1,333.69% | Aug 9, 2023 |
| Barclays | Barclays | Buy Initiates $35 | Buy | Initiates | $35 | +1,154.48% | Jun 15, 2023 |